USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Jubilant Draximage Inc.

USPTO PatentsView assignee record - 20 granted patents across 16 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G21G (CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

17.7

Avg claims per patent

5-year filing velocity

The verdict

Jubilant holds 20 US patents across 16 technology areas, rank #14,709 of 50,000 tracked assignees.

#14,709
of 50,000 US assignees by volume: Top 7%
by Innovation Score (55.3/100): 17.7
avg claims per patent

Portfolio overview

Jubilant Draximage Inc. has been granted 20 US utility patents between 2021 and 2025, placing Jubilant Draximage Inc. at rank #14,709 across all assignees tracked by PlainPatent. This portfolio spans 16 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.7 claims per patent with primary concentration in G21G (CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES). As a Foreign Corporation, Jubilant Draximage Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Jubilant sits between Jost-werke Deutschland Gmbh (20 patents, rank #14,705) and KHD Humboldt Wedag Gmbh (20 patents, rank #14,713) - the closest US assignees by grant volume. The composite Innovation Score of 55.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 20 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Jubilant Draximage Inc.'s 17.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 16 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Jubilant Draximage Inc. against peers pursuing similar technology classes.

Jost-werke Deutsc…

20
JST Power Equipme…

20
Janssen Biopharma

20
Johnson Controls…

20
Just Fur Love

20
Kajeet

20
KEBA

20
KHD Humboldt Wedag

20
Jubilant Draximage ◀

20

What this shows Jubilant holds 20 patents at rank #14,709, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Jubilant

By rank, the assignees closest to #14,709 in granted patent volume.

Leaders in G21G (Conversion OF Chemical Elements)

Other assignees with the most granted patents in Jubilant's primary technology class.

Jubilant's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

55 Top 7% higher than 93% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Jubilant Draximage Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	4	20.0%
2022	2	10.0%
2023	4	20.0%
2024	6	30.0%
2025	4	20.0%

Which technologies does Jubilant Draximage Inc. patent most?

G21G - CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES 9

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 7

G21F - PROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR 6

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 4

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 4

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 2

F04B - POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS 2

G05B - CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS 2

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 2

B01D - SEPARATION 2

C07B - GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR 1

G06V - IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING 1

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 1

C07F - ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM 1

B65B - MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING 1

Top 15 of 16 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Where it ranks

Overall rank by patents

#14,709

Across all tracked assignees

Innovation Score

55.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Jubilant Draximage Inc. hold?

Jubilant Draximage Inc. holds 20 US granted patents filed between 2021 and 2025, spanning 16 technology areas.

What is Jubilant Draximage Inc.'s Innovation Score?

Jubilant Draximage Inc. has an Innovation Score of 55.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Jubilant Draximage Inc. focus on?

Jubilant Draximage Inc.'s top technology area is G21G (CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES) with 9 patents. The company has filed patents in 16 CPC subclasses total.

Is Jubilant Draximage Inc.'s patent filing rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Jubilant Draximage Inc..

What does claim depth mean for Jubilant Draximage Inc.'s patents?

Jubilant Draximage Inc.'s patents average 17.7 claims each. This falls within the standard range, providing solid legal coverage.

How is the Jubilant Draximage Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Jubilant's 20 grants land it in the top 7% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Jubilant ranks #14,709 of 50,000. Top 50 holders
Most of this portfolio concentrates in G21G - see who else leads that technology area. G21G leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.